Pharmaceutical design and development of perfluorocarbon nanocolloids for oxygen delivery in regenerative medicine

Nanomedicine (Lond). 2019 Oct;14(20):2697-2712. doi: 10.2217/nnm-2019-0260. Epub 2019 Oct 28.

Abstract

Perfluorocarbons (PFCs) have been investigated as oxygen carriers for several decades in varied biomedical applications. PFCs are chemically and biologically inert, temperature and storage stable, pose low to no infectious risk, can be commercially manufactured, and have well established gas transport properties. In this review, we highlight design and development strategies for their successful application in regenerative medicine, transplantation and organ preservation. Effective tissue preservation strategies are key to improving outcomes of extremity salvage and organ transplantation. Maintaining tissue integrity requires adequate oxygenation to support aerobic metabolism. The use of whole blood for oxygen delivery is fraught with limitations of poor shelf stability, infectious risk, religious exclusions and product shortages. Other agents also face clinical challenges in their implementation. As a solution, we discuss new ways of designing and developing PFC-based artificial oxygen carriers by implementing modern pharmaceutical quality by design and scale up manufacturing methodologies.

Keywords: imaging; nanocolloids; nanoemulsions; nanomedicine; perfluorocarbons; preservation; quality by design; regenerative medicine; theranostics; transplantation.

Publication types

  • Review

MeSH terms

  • Biological Transport / drug effects
  • Colloids / chemistry
  • Colloids / therapeutic use*
  • Drug Design*
  • Fluorocarbons / therapeutic use
  • Humans
  • Lung / drug effects
  • Lung / pathology
  • Organ Preservation / methods
  • Oxygen / chemistry
  • Oxygen / therapeutic use*
  • Regenerative Medicine / trends*

Substances

  • Colloids
  • Fluorocarbons
  • Oxygen